Expertise in
2
conditions

Paolo Bidoli

Monza, IT 
Expertise in
2
conditions
Monza, IT 

Overview

Paolo Bidoli practices practicing medicine in Monza, Italy.

Mr. Bidoli is highly rated in 2 conditions, according to our data. His clinical expertise encompasses Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Mesothelioma, and EGFR Positive Lung Cancer.

He is actively involved in clinical research, co-authoring 67 peer reviewed articles and participating in 2 clinical trials.

Gender

Male

Locations

Monza, 20900, Italy
Other Locations
Via Pergolesi, Milan, Italy
Besançon, France, St Petersburg City Oncology Dispensary, St Petersburg, Bydgoszcz, Ewa Chmielowska, Centrum Onkologii Im. Prof Franciszka Lukaszczyka Oddzial Kliniczny Onkologii, Bydgoszcz And Uniwersytet Mikolaja Kopernika Torun, Torun, Boguslawa Karaszewska, Przychodnia Lekarska KOMED, Ul Wojska Polskiego 6, Nottingham, Glaxo, Rome, Italy

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Randomised, Open-label Phase III Trial Evaluating the Addition of Denosumab to Standard First-line Anticancer Treatment in Advanced NSCLC
A Randomised, Open-label Phase III Trial Evaluating the Addition of Denosumab to Standard First-line Anticancer Treatment in Advanced NSCLC
Enrollment Status: Terminated
Publish Date: September 08, 2026
Intervention Type: Other, Drug
Study Phase: Phase 3
ATREUS Trial - A Phase II Study on the Activity of Trabectedin of Pretreated Epithelioid or Biphasic / Sarcomatoid Malignant Pleural Mesothelioma(MPM)
ATREUS Trial - A Phase II Study on the Activity of Trabectedin of Pretreated Epithelioid or Biphasic / Sarcomatoid Malignant Pleural Mesothelioma(MPM)
Enrollment Status: Completed
Publish Date: January 23, 2020
Intervention Type: Drug
Study Phase: Phase 2
View 1 Less Clinical Trial

67 Total Publications

Vanishing bile duct syndrome following pembrolizumab infusion: case report and review of the literature.
Vanishing bile duct syndrome following pembrolizumab infusion: case report and review of the literature.
Journal: Immunotherapy
Published: December 07, 2021

Frequently Asked Questions about Paolo Bidoli

Is Paolo Bidoli a top-rated expert for Lung Cancer?

MediFind is an objective health platform that identifies experts based on real-world data. Paolo Bidoli is classified as an Advanced expert for Lung Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Paolo Bidoli participate in research or clinical trials?

Yes. Paolo Bidoli has published 67 articles and abstracts on conditions like Lung Cancer. You can view a list of Paolo Bidoli's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Bidoli's expertise for a condition
ConditionClose
      View All 10 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile